Rogaine Foam

GPTKB entity

Properties (55)
Predicate Object
gptkbp:instanceOf topical medication
gptkbp:activeDuring minoxidil
gptkbp:availability widely available in pharmacies
gptkbp:availableIn over-the-counter
gptkbp:brand gptkb:Rogaine
gptkbp:clinicalTrials Phase III
not recommended for children
consult doctor if using other medications
not for use in pregnant women
proven effective for androgenetic alopecia
treatment of female pattern hair loss
treatment of male pattern baldness
gptkbp:colors white
gptkbp:communityFeedback mixed results
gptkbp:contraindication headache
rash
shortness of breath
scalp conditions
heart palpitations
allergy to minoxidil
swelling of hands or feet
gptkbp:dosageForm topical foam
gptkbp:duration at least 4 months for results
gptkbp:evaluates varies by individual
gptkbp:formulation foam
gptkbp:hasMuseum safe for most users
https://www.w3.org/2000/01/rdf-schema#label Rogaine Foam
gptkbp:impact ongoing for maintenance
gptkbp:lastProduced 1988
gptkbp:launchSite applied to the scalp
gptkbp:manufacturer gptkb:Johnson_&_Johnson
gptkbp:marketedAs gptkb:Rogaine
gptkbp:packaging aerosol can
gptkbp:patentStatus patented
gptkbp:patentType yes
gptkbp:priceRange varies by retailer
gptkbp:regulatoryCompliance approved_by_FDA
gptkbp:safetyFeatures generally well tolerated
gptkbp:sideEffect dizziness
chest pain
weight gain
scalp irritation
unwanted facial hair growth
gptkbp:storage room temperature
gptkbp:suitableFor twice daily
gptkbp:targets men and women
gptkbp:texture light and non-greasy
gptkbp:triggerType vasodilator
gptkbp:trimLevels neutral
gptkbp:type minoxidil foam
gptkbp:usedFor hair loss
gptkbp:uses avoid contact with eyes
apply to dry scalp
wash hands after use
do not rinse after application